Pravastatin in hyperlipidemia secondary to HIV protease inhibitors without response to fenofibrate: a brief preliminary report.
de Luis
Daniel A
DA
Unit of Investigation, Hospital Universitario del Río Hortega, Valladolid, Spain. dadluis@yahoo.es
Bachiller
P
P
Aller
R
R
Eiros Bouza
J
J
Izaola
O
O
D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D005260:Female; D011345:Fenofibrate / Q000494:pharmacology / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D015497:HIV-1 / Q000201:enzymology; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000494:pharmacology; D008297:Male; D017035:Pravastatin / Q000627:therapeutic use*; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D017320:HIV Protease Inhibitors; D000960:Hypolipidemic Agents; D017035:Pravastatin; D011345:Fenofibrate